SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea
· Delayed Price · Currency is KRW 849.00
-47.00 (-5.25%)
At close: Jun 13, 2025, 3:30 PM KST
SCM Lifescience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -10,704 | -12,377 | -23,961 | -22,930 | -22,519 | -9,633 | Upgrade
|
| Depreciation & Amortization | 864.99 | 859.21 | 839.44 | 1,041 | 1,136 | 1,231 | Upgrade
|
| Loss (Gain) From Sale of Assets | 267.05 | 267.05 | - | - | 0.48 | 1.38 | Upgrade
|
| Asset Writedown & Restructuring Costs | 65.27 | 65.27 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,088 | 1,086 | 59.16 | - | - | -15,229 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 10,673 | 11,650 | 9,999 | 6,043 | Upgrade
|
| Stock-Based Compensation | -73.37 | 41.96 | 614.04 | 664.68 | -1,974 | 4,297 | Upgrade
|
| Other Operating Activities | -954.38 | -806.91 | 118.18 | -1,218 | 374.22 | 2,739 | Upgrade
|
| Change in Accounts Receivable | -389.84 | 57.61 | -100.78 | 11.17 | 1.8 | -4.2 | Upgrade
|
| Change in Inventory | -29.43 | -142.96 | -289.35 | 176.97 | -243.66 | 273.53 | Upgrade
|
| Change in Other Net Operating Assets | 528.42 | 896.71 | -88.33 | -579.09 | -178.57 | -609.09 | Upgrade
|
| Operating Cash Flow | -9,337 | -10,053 | -12,136 | -11,184 | -13,404 | -10,890 | Upgrade
|
| Capital Expenditures | -8,102 | -4,074 | -235.57 | -504.83 | -676 | -1,480 | Upgrade
|
| Sale (Purchase) of Intangibles | -332.88 | -305.33 | -8.05 | - | - | -7.9 | Upgrade
|
| Investment in Securities | 6,602 | 6,969 | -7,265 | 16,000 | 16,957 | -23,407 | Upgrade
|
| Other Investing Activities | 53.42 | 53.42 | 498.83 | -496.86 | -489.46 | 1,238 | Upgrade
|
| Investing Cash Flow | -1,780 | 2,643 | -7,010 | 14,998 | 15,791 | -23,657 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 2,000 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 3,150 | - | 3,630 | - | - | Upgrade
|
| Total Debt Issued | 3,150 | 3,150 | - | 5,630 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -2,000 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -186.43 | -148.91 | -6,091 | -474.9 | -512.04 | Upgrade
|
| Total Debt Repaid | -207.88 | -186.43 | -2,149 | -6,091 | -474.9 | -512.04 | Upgrade
|
| Net Debt Issued (Repaid) | 2,942 | 2,964 | -2,149 | -460.78 | -474.9 | -512.04 | Upgrade
|
| Issuance of Common Stock | 7,979 | - | 19,333 | 674.38 | 907.7 | 32,263 | Upgrade
|
| Repurchase of Common Stock | - | - | -16.56 | - | - | - | Upgrade
|
| Other Financing Activities | 0.09 | 0.09 | -441.82 | -1.86 | -7.52 | -1,562 | Upgrade
|
| Financing Cash Flow | 10,922 | 2,964 | 16,725 | 211.73 | 425.29 | 30,189 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -194.45 | -4,446 | -2,421 | 4,026 | 2,813 | -4,358 | Upgrade
|
| Free Cash Flow | -17,438 | -14,127 | -12,372 | -11,689 | -14,080 | -12,370 | Upgrade
|
| Free Cash Flow Margin | -1489.36% | -1712.75% | -1778.30% | -2951.85% | -3205.28% | -3865.43% | Upgrade
|
| Free Cash Flow Per Share | -784.82 | -690.44 | -755.88 | -805.93 | -1176.70 | -1165.98 | Upgrade
|
| Cash Interest Paid | 250.34 | 222.3 | 288.38 | 204.31 | 169.73 | 217.05 | Upgrade
|
| Cash Income Tax Paid | 25.38 | 24.79 | -29.73 | 6.69 | -45.53 | -74.57 | Upgrade
|
| Levered Free Cash Flow | -13,734 | -10,030 | -8,706 | -7,677 | -9,620 | -17,089 | Upgrade
|
| Unlevered Free Cash Flow | -13,553 | -9,868 | -8,511 | -7,527 | -9,496 | -16,772 | Upgrade
|
| Change in Net Working Capital | -117.71 | -781.56 | 1,338 | 521.07 | 67.6 | 10,352 | Upgrade
|
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.